Press release3/17/2025, 11:05 AMBioStock: Last trading day for Abliva - the company leaves Nasdaq Stockholm
Regulatory press release3/3/2025, 12:10 PMDelisting of the shares of Abliva: last day of trading 17 March 2025
Regulatory press release2/26/2025, 7:30 AMNotice of Extraordinary General Meeting in Abliva AB (publ)
Regulatory press release2/25/2025, 8:50 AMAbliva applies for delisting and will convene an extraordinary general meeting
Regulatory press release12/15/2024, 7:00 PMStatement by the Board of Directors of Abliva regarding the public cash offer from Pharming
Press release12/9/2024, 7:32 AMAbliva Announces Publication of Results from Phase 1a/b Study of KL1333 in the Scientific Journal Brain
Press release9/16/2024, 6:30 AMJoin Abliva for World Mitochondrial Disease Week 2024, September 16 – 22
Press release8/26/2024, 6:46 AMBioStock: Abliva's CEO - We are the leading programme in mitochondrial disease
Regulatory press release7/19/2024, 6:30 AMPositive interim analysis in Abliva's FALCON study triggers convertible loan conversion
Regulatory press release7/18/2024, 8:22 PMAbliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease